Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Private Branded Generics is a pharmaceutical company specializing in the distribution and labeling of generic medications, operating as a subsidiary of Cardinal Health. The company was a core component of The Harvard Drug Group, which Cardinal Health acquired in 2015 to significantly expand its presence in the generic drug market and telemarketing channels. Private Branded Generics provides a comprehensive portfolio of prescription and over-the-counter (OTC) products under well-established labels such as Major Pharmaceuticals and Rugby Laboratories. Its primary customer base includes independent retail pharmacies, long-term care facilities, and various institutional healthcare providers across the United States. By focusing on high-quality, cost-effective generic alternatives, the company plays a vital role in the pharmaceutical supply chain, ensuring broad access to essential treatments while leveraging the extensive logistics infrastructure of its parent company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Private branded generics.